Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Work In Process (2012 - 2015)

Updated

Grace Therapeutics (GRCE) posted Work In Process of $825.40 for fiscal Q4 2015 (quarter ended Feb 28, 2015), down 99.6% from $197,422 a year earlier.

Analysis

Grace Therapeutics (GRCE) Work In Process (2012 - 2015) Analysis & Trends

Since fiscal Q4 2012, Grace Therapeutics has reported Work In Process for 4 quarters.

  • Annual Work In Process shows a three-year compound annual growth rate of -86.2% (FY2012 to FY2015).
  • In prior fiscal years, Grace Therapeutics' Work In Process was $219,593 in FY2014, $1,033 in FY2013 (-99.7%) and $311,378 in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Grace Therapeutics 35.10 Mn -35.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Feb 28, 2015 825.40
Feb 28, 2014 197,422.46
Feb 28, 2013 1,009.33
Feb 29, 2012 311,378.00
API Access

Grace Therapeutics Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=GRCE&period=max&api_key=YOUR_API_KEY